Director/PDMR share purchases
Summary by AI BETAClose X
|
FOR RELEASE ON |
5 August 2026 |
IP Group - Director/PDMR share purchases
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and technology companies with the potential to create a better future for all, has been notified that on 4 and 5 August 2026, Michael Queen, the Group's Non-executive Chair, Greg Smith, the Group's Chief Executive Officer, and David Baynes, the Group's Chief Financial and Operating Officer, purchased between them a total of 271,368 Shares of 2p each as outlined in the table below.
|
Name |
Number of shares acquired |
Price per share |
Resulting beneficial interest |
|
Michael Queen |
200,000 |
66.20p |
200,000 |
|
Greg Smith |
45,000 |
67.97p |
1,095,890 |
|
David Baynes |
26,368 |
67.89p |
832,771 |
The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Michael Queen |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Non-executive Chair
|
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
IP Group plc |
||||
|
b) |
LEI |
213800HG22UM138WFG43 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 |
||||
|
b) |
Nature of the transaction |
Purchase of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
200,000 66.2p
|
||||
|
e) |
Date of the transaction |
4 August 2026 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Greg Smith |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Executive Officer
|
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
IP Group plc |
||||
|
b) |
LEI |
213800HG22UM138WFG43 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 |
||||
|
b) |
Nature of the transaction |
Purchase of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
45,000 67.97p |
||||
|
e) |
Date of the transaction |
5 August 2026 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
David Baynes |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Financial and Operating Officer
|
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
IP Group plc |
||||
|
b) |
LEI |
213800HG22UM138WFG43 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 |
||||
|
b) |
Nature of the transaction |
Purchase of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
26,368 67.89p
|
||||
|
e) |
Date of the transaction |
5 August 2026 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market |
||||
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Greg Smith, Chief Executive Officer David Baynes, Chief Financial and Operating Officer Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Alex Donaldson |
+44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 10 hours ago Luceco
- 11 hours ago Helios Towers
- 11 hours ago Wise Class A
- 11 hours ago EDX Medical Group Plc
- 12 hours ago Naked Wines